Perinatal treatment of depressio

Not Applicable

• Conditions: Perinatal depression; Mental Health - Depression

• Registration Number: ACTRN12609000831280
• Lead Sponsor: Royal Brisbane Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-09-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

Pregnant, on SSRI/SNRI medications

Exclusion Criteria

Comorbid substance abuse, use of benzodiazepines, and history of or current suicidality

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Maternal mental health as measured by depression rating scales Montgomery Asberg Depression Rating Scale(MADRS ) and Edinburgh Postnatal Depression Scale (EPND)[K28 ( 28 weeks pregnant), K38 (38 weeks pregnant), 3 days, 3 weeks, 3 months and 6 months post partum]

Secondary Outcome Measures

Name	Time	Method
Signs of foetal discontinuation as measured by Finnegan neonatal abstinence score and objective motion sensors[Day 1 to 4 post delivery]